JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB257102

Human SAA1 knockout A549 cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

SAA1 KO cell lysate available now. KO validated by. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 137 bp insertion in exon3 and 1 bp insertion in exon3.

View Alternative Names

Amyloid fibril protein AA, Amyloid protein A, MGC111216, PIG 4, Serum amyloid A 1, Serum amyloid A protein, TP53I4, Tumor protein p53 inducible protein 4, amyloid A, serum, serum amyloid A-1 protein

2 Images
Sanger Sequencing - Human SAA1 knockout A549 cell lysate (AB257102)
  • Sanger seq

Unknown

Sanger Sequencing - Human SAA1 knockout A549 cell lysate (AB257102)

Allele-1 : 137 bp insertion in exon3

Sanger Sequencing - Human SAA1 knockout A549 cell lysate (AB257102)
  • Sanger seq

Unknown

Sanger Sequencing - Human SAA1 knockout A549 cell lysate (AB257102)

Allele-2 : 1 bp insertion in exon3

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 137 bp insertion in exon3 and 1 bp insertion in exon3.

Disease

Carcinoma

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab257102-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human SAA1 knockout A549 cell lysate", "number":"AB257102-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type A549 cell lysate", "number":"AB257102-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SAA1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Serum amyloid A1 (SAA1) is a small protein with a molecular mass of approximately 12 kDa. Researchers also call it SAA or acute phase serum amyloid protein. Hepatocytes mainly express SAA1 during the acute phase response but some expression occurs in other tissues. SAA1 significantly increases in response to inflammatory stimuli acting as an important player in the body's reaction to injury or infection.
Biological function summary

This protein regulates cholesterol metabolism and serves as a chemoattractant directing cell movement towards the sites of inflammation. SAA1 does not exist alone often associating with high-density lipoproteins (HDL) in circulation. By binding to HDL it can aid in transporting cholesterol from tissues to the liver for excretion linking it with both immunological and metabolic processes.

Pathways

Researchers place SAA1 within the inflammation and immune response strategies. It significantly contributes to the acute-phase response and relates to cytokine signaling pathways. SAA1 interacts with proteins such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) which are central to the activation and propagation of inflammatory responses in tissues.

SAA1 closely associates with chronic inflammatory conditions and amyloidosis. Excessive SAA1 levels can lead to amyloid A (AA) amyloidosis where protein fragments deposit abnormally in organs. It also plays a role in conditions like rheumatoid arthritis where inflammation perpetuates disease progression. Interestingly SAA1 levels correlate with C-reactive protein (CRP) another marker of inflammation frequent in similar disorders.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com